Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease--authors' reply
Aliment Pharmacol Ther
.
2015 Jul;42(2):241.
doi: 10.1111/apt.13262.
Authors
M J Rosen
1
2
,
P Minar
3
4
,
A A Vinks
4
5
Affiliations
1
Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. michael.rosen@cchmc.org.
2
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. michael.rosen@cchmc.org.
3
Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
4
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
5
Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
PMID:
26081689
DOI:
10.1111/apt.13262
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal / therapeutic use*
Colitis, Ulcerative / drug therapy*
Humans
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
Grants and funding
K23 DK105229/DK/NIDDK NIH HHS/United States